Balloon Catheter Drug Coating Uniformity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for coating percutaneous transluminal angioplasty (PTA) balloon catheters are inconsistent, non-uniform, labor-intensive, and environmentally unfriendly, leading to high incidence of restenosis and late in-stent thrombosis, necessitating improved therapies for occlusive vascular disease treatment.
Innovation Solution
A method involving a coating solution with paclitaxel, iopromide, acetone, and ethanol is applied to the balloon catheter, providing a uniform, conformal coating with controlled particulate release and retention, ensuring effective drug delivery to the vessel wall while minimizing systemic exposure and manufacturing costs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If standard dip coating methods are used to coat PTA catheter balloons, then the coating process is simple to implement, but the coating becomes inconsistent, non-uniform, and shreds away during handling
Solution Approach 1:
A polymer adhesive layer is applied as an intermediary between the balloon surface and the therapeutic agent coating. This adhesive layer provides a bonding interface that ensures uniform adhesion and prevents coating shredding during handling, while allowing the coating process to remain relatively simple
Solution Approach 2:
The coating process parameters are optimized including solvent composition (acetone/ethanol/water ratios), coating solution concentration (30-90 mg/ml paclitaxel), and drying conditions. These parameter changes ensure uniform coating deposition and prevent non-uniformity while maintaining process simplicity
2Ease of manufacture
If standard dip coating methods are used, then the manufacturing process is straightforward, but the coating process becomes very labor intensive and lengthy
Solution Approach 1:
The coating process is designed as a continuous operation where the balloon catheter passes through coating and drying zones without interruption. The coating solution is applied continuously and drying occurs in a controlled environment, eliminating labor-intensive manual handling steps and reducing overall process time
Solution Approach 2:
Manual dip coating operations are replaced with automated coating application systems that deliver the coating solution uniformly along the balloon surface. This substitution reduces labor intensity and increases manufacturing efficiency while maintaining ease of process implementation
3Ease of manufacture
If standard dip coating methods are used, then the coating application is simple, but the process becomes environmentally unfriendly
Solution Approach 1:
The solvent system is reformulated with optimized ratios of acetone, ethanol, and water that reduce environmental impact. The coating solution concentration is precisely controlled (30-90 mg/ml paclitaxel in specific solvent ratios) to minimize waste and improve environmental compatibility while maintaining coating quality
Solution Approach 2:
The coating and drying process is conducted in a controlled environment that minimizes environmental release of coating materials. The drying zone is designed to contain and recover solvents, creating a more environmentally friendly process while keeping the coating application simple
4Device complexity
If non-uniform coating is applied to the balloon, then the manufacturing process is simpler, but the drug delivery becomes inconsistent leading to high restenosis incidence
Solution Approach 1:
The polymer adhesive layer serves as a mediator that ensures uniform distribution and adhesion of the therapeutic agent to the balloon surface. This intermediary layer prevents coating non-uniformity and ensures consistent drug delivery to the vessel wall, reducing restenosis incidence
Solution Approach 2:
Precise control of coating solution parameters including paclitaxel concentration (30-90 mg/ml), solvent composition (acetone/ethanol/water ratios), and drying conditions ensures uniform coating thickness and consistent drug delivery. This parameter optimization improves reliability of restenosis prevention without excessive complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves a significant reduction in restenosis incidence, maintains drug retention on the balloon surface, and ensures uniform drug transfer to the vessel wall, addressing the limitations of existing coating techniques.
Implementation Method 1
coating the balloon with the coating solution and drying the coating solution on the balloon to provide a balloon catheter having a dried coating on the external surface of the balloon
Data Source
Figure 1
Figure 2
AI summary
A composition and methods for improved delivery of a therapeutic agent to a stenosed vessel wall.